Skip to main content
COLLEGIUM PHARMACEUTICAL, INC logo

COLLEGIUM PHARMACEUTICAL, INC — Investor Relations & Filings

Ticker · COLL ISIN · US19459J1043 LEI · 54930049FXZMTLW8D496 US Manufacturing
Open in API
Filings indexed 821 across all filing types
Latest filing 2015-05-12 Governance Information
Country US United States of America
Listing US COLL

About COLLEGIUM PHARMACEUTICAL, INC

https://www.collegiumpharma.com/

Collegium Pharmaceutical, Inc. is a diversified biopharmaceutical company that develops and commercializes medicines for people with serious medical conditions. The company is focused on building a portfolio of differentiated medications. Its primary area of expertise is in pain management, where it develops products with abuse-deterrent properties designed to be safer alternatives for patients and the community.

Recent filings

Filing Released Lang Actions
8-K
Governance Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated May 12, 2015, by Collegium Pharmaceutical, Inc. The content focuses on amendments to the Articles of Incorporation and Bylaws, including the adoption of amended and restated versions of these documents. There is no financial data or discussion of financial results, nor is this a report of voting results or a proxy statement. The document announces changes to corporate governance documents, specifically the Articles of Incorporation and Bylaws, which are related to the company's board structure and governance practices. Therefore, the most appropriate classification is Governance Information (CGR). The document length is over 5,000 characters and contains substantive content, not just an announcement or certification, supporting this classification.
2015-05-12 English
FORM 3/A SUBMISSION
Director's Dealing
2015-05-12 English
FORM 3 SUBMISSION
Director's Dealing
2015-05-08 English
424B4
Capital/Financing Update Classification · 95% confidence The document is a detailed prospectus for an initial public offering (IPO) of common stock by Collegium Pharmaceutical, Inc. It includes extensive information such as the offering price, underwriting details, risk factors, management discussion, financial data, and legal matters. The presence of the term 'Prospectus' and the detailed offering information indicates this is a registration statement or offering document related to capital raising. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. The document is lengthy (15,000 characters) and contains substantive content, not just an announcement or a brief summary, so it is not a Report Publication Announcement or Regulatory Filing. Therefore, the correct classification is CAP with high confidence.
2015-05-07 English
Regulatory Filings 2015
Regulatory Filings
2015-05-07 English
OWNERSHIP DOCUMENT
Director's Dealing
2015-05-06 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.